Compare Stocks

iShares Government/Credit Bond ETF (the Fund) is an exchange-traded fund. The Fund seeks to track the investment results of an index composed of the United States dollar-denominated government, government-related and investment-grade the United States corporate bonds. The Fund seeks to track the investment results of the Barclays U.S. Government/Credit Bond Index (the Underlying Index), which measures the performance of the United States dollar-denominated United States Treasury bonds, government-related bonds (i.e., the United States and foreign agencies, sovereign, supranational and local authority debt) and investment-grade United States corporate bonds, which have a remaining maturity of greater than or equal to one year. The Underlying Index may include large-, mid- or small-capitalization companies, and components include agency and treasury securities, and financial and industrials companies. BlackRock Fund Advisors serves as investment adviser of the Fund.

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-3215, an anti-HER2 monoclonal antibody candidate; and HSB-1940, a Quatrabody that is a proprietary IO biologic in development targeting PD-1. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.